Chartwell Molecules Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?
CHARTWELL MOLECULES has twenty-one approved drugs.
Drugs and US Patents for Chartwell Molecules
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Molecules | CIMETIDINE | cimetidine | TABLET;ORAL | 074329-001 | May 17, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecules | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | TABLET;ORAL | 074093-002 | Nov 5, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecules | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 077406-002 | Dec 26, 2006 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecules | NAPROXEN | naproxen | TABLET;ORAL | 074410-001 | Apr 28, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.